CA9 and renal cell carcinoma: A clinical trial with 12 patients with CAIX-expressing metastatic renal cell carcinoma (RCC) treated with CAR T cells against CAIX showed that low-dose CAR T cells induced antigen-specific liver toxicity due to CAIX expression on bile duct epithelium.